Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer

BACKGROUND: Biomarkers for metastatic castration-resistant prostatic cancer (mCRPC) are an unmet medical need. METHODS: The prognostic and predictive value for survival and response to salvage hormonal therapy (SHT) of baseline testosterone level (TL) was analysed in a cohort of 101 mCRPC patients p...

Descripción completa

Detalles Bibliográficos
Autores principales: de Liaño, A G, Reig, O, Mellado, B, Martin, C, Rull, E U, Maroto, J P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007243/
https://www.ncbi.nlm.nih.gov/pubmed/24722180
http://dx.doi.org/10.1038/bjc.2014.189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007243/
https://www.ncbi.nlm.nih.gov/pubmed/24722180
http://dx.doi.org/10.1038/bjc.2014.189

Ejemplares similares